Attention deficit hyperactivity disorder (ADHD). Attention-deficit hyperactivity disorder, predominantly inattentive type
Conditions
Interventions
Intervention 1: Intervention group: They receive supplements containing 800 micrograms of vitamin A every other day for 8 weeks. Vitamin A supplement includes soft gelatin capsules of Vitamin A, Eurov
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Age 6 to 12 years Diagnosis of ADHD based on the diagnosis of a child and adolescent psychiatrist according to DSM-V criteria Candidate to receive methylphenidate drug Low vitamin A dietary intake in children, according to the list of foods containing vitamin A Signing a written consent form by the child and one of the child's parents
Exclusion criteria
Exclusion criteria: Presence of any major concurrent psychiatric illness such as autism, bipolar disorder and any major neurological illness such as epilepsy based on a psychiatrist's diagnosis Use of any medication, including drugs affecting the nervous system, at least 4 weeks before the start of the study Use of dietary and herbal supplements including probiotics and vitamin D in the past two months Suffering from any systemic illness, including liver, kidney, thyroid, and cardiovascular diseases, as well as diabetes, fat malabsorption, and infectious diseases based on the patient's history History of severe head injury
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of symptoms according to Conner’s Parent Questionnaire score. Timepoint: At the beginning of the study and at weeks 4 and 8 of the intervention. Method of measurement: Conner’s Parent Rating Scale Questionnaire.;Severity of symptoms according to Attention Deficit Hyperactivity Disorder Rating Scale Questionnaire score. Timepoint: At the beginning of the study and at weeks 4 and 8 of the intervention. Method of measurement: Attention Deficit Hyperactivity Disorder Rating Scale Questionnaire.;Severity of symptoms according to the evening and morning behavior questionnaire score. Timepoint: At the beginning of the study and at weeks 4 and 8 of the intervention. Method of measurement: Parent Ratings of Evening and Morning Behavior questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: At the beginning and end of the intervention. Method of measurement: Digital scale.;Height. Timepoint: At the beginning and end of the intervention. Method of measurement: Wall-mounted thermometer.;Body mass index. Timepoint: At the beginning and end of the intervention. Method of measurement: Ratio of weight in kilograms to the square of height in meters.;Waist. Timepoint: At the beginning and end of the intervention. Method of measurement: Tape measure. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKiyana Talatifar
Iran University of Medical Sciences
Outcome results
None listed